Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Bunke

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Transplantation|April 1, 1988
Use of OKT3 monoclonal antibody in the treatment of acute cardiac allograft rejectionJ B Klein, K R McLeish, C M Bunke, et al.
Transplantation Proceedings|August 1, 1996
Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Transplantation|March 27, 1996
The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients. The Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Transplantation|April 1, 1988
Use of OKT3 monoclonal antibody in the treatment of acute cardiac allograft rejectionJ B Klein, K R McLeish, C M Bunke, et al.
Transplantation Proceedings|August 1, 1996
Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Transplantation|March 27, 1996
The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients. The Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Pageof 2